KKR to acquire Integer Holdings for $5.7 billion, taking it private

Published Aug 3, 11:42 AM UTC

Global investment firm KKR has agreed to acquire medical device manufacturer Integer Holdings for approximately $5.7 billion in an all-cash transaction. Integer stockholders will receive about $127 per share, a more than 51% premium to the company's closing price before its strategic review was announced in April. Integer, which bills itself as one of the largest global medical device contract development and manufacturing organizations, makes finished devices and components such as electrophysiology catheters, cardiac leads, and batteries, serving medtech firms including Abbott, Boston Scientific, and Medtronic. The acquisition is expected to close by the end of 2026, subject to regulatory approvals and shareholder support. Integer reported $464 million in sales for the second quarter of 2026, a 2.6% decrease. The deal is intended to provide Integer with flexibility and long-term capital to invest in capacity, technology, and innovation.